Rank | Gene Set | Z-score |
---|---|---|
1 | melanin biosynthetic process (GO:0042438) | 6.12364189 |
2 | secondary metabolite biosynthetic process (GO:0044550) | 5.77634889 |
3 | proteasome assembly (GO:0043248) | 5.54269242 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.51551335 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.51551335 |
6 | L-phenylalanine catabolic process (GO:0006559) | 5.40970944 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.40970944 |
8 | melanin metabolic process (GO:0006582) | 5.32772473 |
9 | aromatic amino acid family catabolic process (GO:0009074) | 4.87132608 |
10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.77152952 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.60400111 |
12 | L-ascorbic acid metabolic process (GO:0019852) | 4.53126647 |
13 | sulfur amino acid catabolic process (GO:0000098) | 4.51528428 |
14 | bile acid biosynthetic process (GO:0006699) | 4.51517841 |
15 | glyoxylate metabolic process (GO:0046487) | 4.44925610 |
16 | high-density lipoprotein particle remodeling (GO:0034375) | 4.39460828 |
17 | negative regulation of fibrinolysis (GO:0051918) | 4.37538055 |
18 | tryptophan catabolic process (GO:0006569) | 4.36764138 |
19 | indole-containing compound catabolic process (GO:0042436) | 4.36764138 |
20 | indolalkylamine catabolic process (GO:0046218) | 4.36764138 |
21 | cysteine metabolic process (GO:0006534) | 4.35085025 |
22 | regulation of protein activation cascade (GO:2000257) | 4.34783355 |
23 | ethanol oxidation (GO:0006069) | 4.31540709 |
24 | serine family amino acid catabolic process (GO:0009071) | 4.31243423 |
25 | aldehyde catabolic process (GO:0046185) | 4.26408592 |
26 | kynurenine metabolic process (GO:0070189) | 4.17474038 |
27 | regulation of complement activation (GO:0030449) | 4.15684746 |
28 | regulation of fibrinolysis (GO:0051917) | 4.13211024 |
29 | tryptophan metabolic process (GO:0006568) | 4.12708031 |
30 | ATP synthesis coupled proton transport (GO:0015986) | 4.03951383 |
31 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.03951383 |
32 | response to nitrosative stress (GO:0051409) | 4.02793834 |
33 | alkaloid metabolic process (GO:0009820) | 3.96646354 |
34 | regulation of cholesterol esterification (GO:0010872) | 3.94910281 |
35 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.94375954 |
36 | imidazole-containing compound metabolic process (GO:0052803) | 3.88899115 |
37 | epoxygenase P450 pathway (GO:0019373) | 3.86335276 |
38 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.79864248 |
39 | coenzyme catabolic process (GO:0009109) | 3.79468795 |
40 | tyrosine metabolic process (GO:0006570) | 3.79052398 |
41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.78928444 |
42 | glycine metabolic process (GO:0006544) | 3.77991419 |
43 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.77851778 |
44 | cullin deneddylation (GO:0010388) | 3.76796520 |
45 | urea cycle (GO:0000050) | 3.74209984 |
46 | urea metabolic process (GO:0019627) | 3.74209984 |
47 | aromatic amino acid family metabolic process (GO:0009072) | 3.73392903 |
48 | protein K6-linked ubiquitination (GO:0085020) | 3.72790428 |
49 | reverse cholesterol transport (GO:0043691) | 3.71782402 |
50 | xenobiotic catabolic process (GO:0042178) | 3.71161649 |
51 | phospholipid efflux (GO:0033700) | 3.69512052 |
52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.67492488 |
53 | protein-lipid complex remodeling (GO:0034368) | 3.67492488 |
54 | macromolecular complex remodeling (GO:0034367) | 3.67492488 |
55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.67320544 |
56 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.66299520 |
57 | glutathione derivative metabolic process (GO:1901685) | 3.64475958 |
58 | glutathione derivative biosynthetic process (GO:1901687) | 3.64475958 |
59 | bile acid metabolic process (GO:0008206) | 3.63476488 |
60 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.63452035 |
61 | cellular glucuronidation (GO:0052695) | 3.62329603 |
62 | amino-acid betaine metabolic process (GO:0006577) | 3.62017871 |
63 | serine family amino acid metabolic process (GO:0009069) | 3.62003200 |
64 | protein carboxylation (GO:0018214) | 3.61612028 |
65 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.61612028 |
66 | complement activation, alternative pathway (GO:0006957) | 3.61477468 |
67 | negative regulation of ligase activity (GO:0051352) | 3.59282597 |
68 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.59282597 |
69 | homocysteine metabolic process (GO:0050667) | 3.57515013 |
70 | alpha-amino acid catabolic process (GO:1901606) | 3.54895188 |
71 | chaperone-mediated protein transport (GO:0072321) | 3.54576390 |
72 | regulation of mitochondrial translation (GO:0070129) | 3.54449311 |
73 | nitrogen cycle metabolic process (GO:0071941) | 3.54220911 |
74 | fibrinolysis (GO:0042730) | 3.54037166 |
75 | arginine metabolic process (GO:0006525) | 3.52961753 |
76 | chromatin remodeling at centromere (GO:0031055) | 3.51761339 |
77 | regulation of triglyceride catabolic process (GO:0010896) | 3.50948386 |
78 | protein deneddylation (GO:0000338) | 3.47350446 |
79 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.46429212 |
80 | glucuronate metabolic process (GO:0019585) | 3.46226394 |
81 | uronic acid metabolic process (GO:0006063) | 3.46226394 |
82 | primary alcohol catabolic process (GO:0034310) | 3.45299085 |
83 | phenol-containing compound catabolic process (GO:0019336) | 3.44627352 |
84 | respiratory electron transport chain (GO:0022904) | 3.44622703 |
85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.43203646 |
86 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.43203646 |
87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.43203646 |
88 | CENP-A containing nucleosome assembly (GO:0034080) | 3.43171379 |
89 | alpha-linolenic acid metabolic process (GO:0036109) | 3.41461239 |
90 | electron transport chain (GO:0022900) | 3.41312282 |
91 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.39857546 |
92 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.39857546 |
93 | negative regulation of protein activation cascade (GO:2000258) | 3.39161785 |
94 | benzene-containing compound metabolic process (GO:0042537) | 3.36637377 |
95 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.35926022 |
96 | rRNA modification (GO:0000154) | 3.35437781 |
97 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.33533717 |
98 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.33533717 |
99 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.33464833 |
100 | bile acid and bile salt transport (GO:0015721) | 3.32917894 |
101 | low-density lipoprotein particle remodeling (GO:0034374) | 3.31720786 |
102 | respiratory chain complex IV assembly (GO:0008535) | 3.30751555 |
103 | cellular biogenic amine catabolic process (GO:0042402) | 3.30298005 |
104 | amine catabolic process (GO:0009310) | 3.30298005 |
105 | maturation of 5.8S rRNA (GO:0000460) | 3.28253071 |
106 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.27805789 |
107 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.27538368 |
108 | ethanol metabolic process (GO:0006067) | 3.27185216 |
109 | negative regulation of sterol transport (GO:0032372) | 3.26737462 |
110 | negative regulation of cholesterol transport (GO:0032375) | 3.26737462 |
111 | cofactor catabolic process (GO:0051187) | 3.26069204 |
112 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.25854512 |
113 | cellular amino acid catabolic process (GO:0009063) | 3.24311435 |
114 | protein complex biogenesis (GO:0070271) | 3.23928493 |
115 | heme transport (GO:0015886) | 3.22971762 |
116 | DNA replication checkpoint (GO:0000076) | 3.22788346 |
117 | triglyceride homeostasis (GO:0070328) | 3.19055308 |
118 | acylglycerol homeostasis (GO:0055090) | 3.19055308 |
119 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.16348976 |
120 | NADH dehydrogenase complex assembly (GO:0010257) | 3.16348976 |
121 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.16348976 |
122 | plasma lipoprotein particle clearance (GO:0034381) | 3.15559771 |
123 | blood coagulation, intrinsic pathway (GO:0007597) | 3.13465602 |
124 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.11728684 |
125 | indolalkylamine metabolic process (GO:0006586) | 3.10803941 |
126 | drug catabolic process (GO:0042737) | 3.10430553 |
127 | pigment biosynthetic process (GO:0046148) | 3.09526448 |
128 | purine nucleobase biosynthetic process (GO:0009113) | 3.09492971 |
129 | serine family amino acid biosynthetic process (GO:0009070) | 3.08509211 |
130 | negative regulation of blood coagulation (GO:0030195) | 3.05874167 |
131 | negative regulation of hemostasis (GO:1900047) | 3.05874167 |
132 | drug metabolic process (GO:0017144) | 3.05380540 |
133 | arginine catabolic process (GO:0006527) | 3.05175261 |
134 | flavonoid metabolic process (GO:0009812) | 3.05120840 |
135 | positive regulation of ligase activity (GO:0051351) | 3.02801661 |
136 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.01845241 |
137 | termination of RNA polymerase III transcription (GO:0006386) | 3.01845241 |
138 | nucleobase biosynthetic process (GO:0046112) | 2.98911846 |
139 | cellular modified amino acid catabolic process (GO:0042219) | 2.98244003 |
140 | carnitine metabolic process (GO:0009437) | 2.98156196 |
141 | cholesterol efflux (GO:0033344) | 2.98043571 |
142 | negative regulation of complement activation (GO:0045916) | 2.97460697 |
143 | protein targeting to mitochondrion (GO:0006626) | 2.96888879 |
144 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.95363582 |
145 | rRNA methylation (GO:0031167) | 2.94868703 |
146 | exogenous drug catabolic process (GO:0042738) | 2.94845129 |
147 | glutamate metabolic process (GO:0006536) | 2.94693307 |
148 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.93049357 |
149 | platelet dense granule organization (GO:0060155) | 2.92355541 |
150 | ketone body metabolic process (GO:1902224) | 2.90731054 |
151 | cytochrome complex assembly (GO:0017004) | 2.90409828 |
152 | protein neddylation (GO:0045116) | 2.89821724 |
153 | L-serine metabolic process (GO:0006563) | 2.88449812 |
154 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.88270599 |
155 | regulation of cellular amine metabolic process (GO:0033238) | 2.88181486 |
156 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.88162646 |
157 | spliceosomal snRNP assembly (GO:0000387) | 2.86384773 |
158 | histone exchange (GO:0043486) | 2.86339054 |
159 | peptidyl-histidine modification (GO:0018202) | 2.85785350 |
160 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.85230200 |
161 | negative regulation of coagulation (GO:0050819) | 2.84901700 |
162 | mitochondrial RNA metabolic process (GO:0000959) | 2.84421624 |
163 | organic acid catabolic process (GO:0016054) | 2.83838243 |
164 | carboxylic acid catabolic process (GO:0046395) | 2.83838243 |
165 | negative regulation of lipase activity (GO:0060192) | 2.82474495 |
166 | regulation of ligase activity (GO:0051340) | 2.81774630 |
167 | anterior/posterior axis specification, embryo (GO:0008595) | 2.79374125 |
168 | polyketide metabolic process (GO:0030638) | 2.79190515 |
169 | doxorubicin metabolic process (GO:0044598) | 2.79190515 |
170 | daunorubicin metabolic process (GO:0044597) | 2.79190515 |
171 | lysine catabolic process (GO:0006554) | 2.78436437 |
172 | lysine metabolic process (GO:0006553) | 2.78436437 |
173 | DNA strand elongation (GO:0022616) | 2.78098520 |
174 | protein-cofactor linkage (GO:0018065) | 2.78087095 |
175 | inner mitochondrial membrane organization (GO:0007007) | 2.76942396 |
176 | establishment of protein localization to mitochondrion (GO:0072655) | 2.76044615 |
177 | pigment metabolic process (GO:0042440) | 2.75278383 |
178 | protein localization to mitochondrion (GO:0070585) | 2.72528945 |
179 | ribosome assembly (GO:0042255) | 2.72414403 |
180 | mitotic metaphase plate congression (GO:0007080) | 2.72257325 |
181 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.70466470 |
182 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.70466470 |
183 | nucleotide transmembrane transport (GO:1901679) | 2.70027181 |
184 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.69311854 |
185 | tRNA aminoacylation for protein translation (GO:0006418) | 2.67094699 |
186 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.65487579 |
187 | mannosylation (GO:0097502) | 2.65154488 |
188 | tRNA aminoacylation (GO:0043039) | 2.64297779 |
189 | amino acid activation (GO:0043038) | 2.64297779 |
190 | replication fork processing (GO:0031297) | 2.63506443 |
191 | metaphase plate congression (GO:0051310) | 2.63347587 |
192 | ATP biosynthetic process (GO:0006754) | 2.62554596 |
193 | oxidative phosphorylation (GO:0006119) | 2.61064232 |
194 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.59205182 |
195 | melanosome organization (GO:0032438) | 2.56292422 |
196 | pseudouridine synthesis (GO:0001522) | 2.55859502 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.90844452 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.70439838 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.45112587 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.35936720 |
5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.31707793 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.18509135 |
7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.15216909 |
8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.89330237 |
9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.89330237 |
10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.89330237 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85724785 |
12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.70876911 |
13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53815773 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.41244653 |
15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.19698828 |
16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.11694723 |
17 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 3.07258835 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.06967779 |
19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.00784671 |
20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.89348327 |
21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.89074196 |
22 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.88619708 |
23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.71447237 |
24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.67601438 |
25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.54748487 |
26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.47735385 |
27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.47462085 |
28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.43601259 |
29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.36141659 |
30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.25390456 |
31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.23263705 |
32 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.17693798 |
33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.12793393 |
34 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.11534462 |
35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.08953235 |
36 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.08076672 |
37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.06737929 |
38 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.05546656 |
39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.02840373 |
40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.01161324 |
41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.00926531 |
42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.99838797 |
43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96565523 |
44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.94765986 |
45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93382971 |
46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.91423107 |
47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.90567939 |
48 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88871315 |
49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.88396808 |
50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87596998 |
51 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.82783020 |
52 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.80404189 |
53 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.78788672 |
54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.76981200 |
55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.73115474 |
56 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.71737933 |
57 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.69650952 |
58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.68552469 |
59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67487632 |
60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67242144 |
61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.66681697 |
62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.62129932 |
63 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.61840529 |
64 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.60282509 |
65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58053823 |
66 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52031449 |
67 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50750253 |
68 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.50158537 |
69 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.48645525 |
70 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47087764 |
71 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.46450374 |
72 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44591183 |
73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43510602 |
74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42907721 |
75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42108287 |
76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41003107 |
77 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.40410113 |
78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39722312 |
79 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38644293 |
80 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34729614 |
81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33298821 |
82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.31800496 |
83 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29271450 |
84 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.28815023 |
85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28239827 |
86 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27943430 |
87 | EWS_26573619_Chip-Seq_HEK293_Human | 1.25450384 |
88 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21588197 |
89 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19197983 |
90 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17643646 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16432784 |
92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14848915 |
93 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.13283675 |
94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13002977 |
95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12768965 |
96 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.11710335 |
97 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10706674 |
98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10344933 |
99 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.08784180 |
100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08507417 |
101 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06727422 |
102 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04485177 |
103 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03336771 |
104 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02430149 |
105 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.02277766 |
106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02060115 |
107 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.01792333 |
108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99276023 |
109 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99223686 |
110 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.98990079 |
111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98499537 |
112 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98106545 |
113 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97408223 |
114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96643755 |
115 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.95299323 |
116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94693370 |
117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94693370 |
118 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93196592 |
119 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92595699 |
120 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92406631 |
121 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.91173571 |
122 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.90647588 |
123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90462055 |
124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89643164 |
125 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89302413 |
126 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89291360 |
127 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.88902234 |
128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88706401 |
129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87737434 |
130 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87403866 |
131 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86884368 |
132 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86474322 |
133 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.86182345 |
134 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86116868 |
135 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85290330 |
136 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85256292 |
137 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84492840 |
138 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.83193453 |
139 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82946146 |
140 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.82943613 |
141 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.82608974 |
142 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.82601606 |
143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81889775 |
144 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81328681 |
145 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.80360989 |
146 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.79885966 |
147 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79749436 |
148 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.78360662 |
149 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.77704407 |
150 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.77575021 |
151 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.77394108 |
152 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.75101357 |
153 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74745508 |
154 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.74546362 |
155 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.74198573 |
156 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.74198573 |
157 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.74181549 |
158 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.74085219 |
159 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.74048483 |
160 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.73570247 |
161 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.73267339 |
162 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.72836122 |
163 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.72228660 |
164 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71110260 |
165 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71110260 |
166 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.70300301 |
167 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.69649170 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000372_irregular_coat_pigmentation | 6.76270726 |
2 | MP0005171_absent_coat_pigmentation | 5.96046244 |
3 | MP0002139_abnormal_hepatobiliary_system | 5.67697429 |
4 | MP0003806_abnormal_nucleotide_metabolis | 5.20541356 |
5 | MP0005085_abnormal_gallbladder_physiolo | 5.13018735 |
6 | MP0005360_urolithiasis | 4.64642785 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.51571478 |
8 | MP0005075_abnormal_melanosome_morpholog | 3.84460823 |
9 | MP0005365_abnormal_bile_salt | 3.78453414 |
10 | MP0002938_white_spotting | 3.06115901 |
11 | MP0002822_catalepsy | 3.01266188 |
12 | MP0000015_abnormal_ear_pigmentation | 3.01189164 |
13 | MP0005083_abnormal_biliary_tract | 2.86600235 |
14 | MP0009697_abnormal_copulation | 2.77919194 |
15 | MP0002095_abnormal_skin_pigmentation | 2.67941387 |
16 | MP0000371_diluted_coat_color | 2.52832008 |
17 | MP0010094_abnormal_chromosome_stability | 2.48113715 |
18 | MP0005167_abnormal_blood-brain_barrier | 2.38654784 |
19 | MP0009840_abnormal_foam_cell | 2.38598217 |
20 | MP0001324_abnormal_eye_pigmentation | 2.24627004 |
21 | MP0002796_impaired_skin_barrier | 2.23764422 |
22 | MP0009379_abnormal_foot_pigmentation | 2.23482773 |
23 | MP0003186_abnormal_redox_activity | 2.19820749 |
24 | MP0010329_abnormal_lipoprotein_level | 2.16375342 |
25 | MP0005174_abnormal_tail_pigmentation | 2.14010625 |
26 | MP0002102_abnormal_ear_morphology | 2.12779386 |
27 | MP0002254_reproductive_system_inflammat | 2.07551515 |
28 | MP0004019_abnormal_vitamin_homeostasis | 2.05808240 |
29 | MP0003705_abnormal_hypodermis_morpholog | 2.04772538 |
30 | MP0003252_abnormal_bile_duct | 2.02265363 |
31 | MP0003941_abnormal_skin_development | 1.97056149 |
32 | MP0004133_heterotaxia | 1.96394853 |
33 | MP0003195_calcinosis | 1.94587826 |
34 | MP0004957_abnormal_blastocyst_morpholog | 1.92060103 |
35 | MP0010030_abnormal_orbit_morphology | 1.82727418 |
36 | MP0002837_dystrophic_cardiac_calcinosis | 1.80738290 |
37 | MP0003693_abnormal_embryo_hatching | 1.79819180 |
38 | MP0005332_abnormal_amino_acid | 1.79427278 |
39 | MP0002090_abnormal_vision | 1.78249758 |
40 | MP0002075_abnormal_coat/hair_pigmentati | 1.73538420 |
41 | MP0002877_abnormal_melanocyte_morpholog | 1.70070862 |
42 | MP0008058_abnormal_DNA_repair | 1.67608852 |
43 | MP0003111_abnormal_nucleus_morphology | 1.66431930 |
44 | MP0003011_delayed_dark_adaptation | 1.62933665 |
45 | MP0005275_abnormal_skin_tensile | 1.62419905 |
46 | MP0008932_abnormal_embryonic_tissue | 1.62026548 |
47 | MP0006036_abnormal_mitochondrial_physio | 1.60377463 |
48 | MP0005451_abnormal_body_composition | 1.56916662 |
49 | MP0002249_abnormal_larynx_morphology | 1.55483095 |
50 | MP0001186_pigmentation_phenotype | 1.55267449 |
51 | MP0003077_abnormal_cell_cycle | 1.48183398 |
52 | MP0002060_abnormal_skin_morphology | 1.43537619 |
53 | MP0002638_abnormal_pupillary_reflex | 1.42625440 |
54 | MP0005253_abnormal_eye_physiology | 1.42174601 |
55 | MP0003136_yellow_coat_color | 1.34691962 |
56 | MP0010368_abnormal_lymphatic_system | 1.33474842 |
57 | MP0005647_abnormal_sex_gland | 1.32800043 |
58 | MP0004272_abnormal_basement_membrane | 1.27071950 |
59 | MP0001542_abnormal_bone_strength | 1.24573277 |
60 | MP0005501_abnormal_skin_physiology | 1.23907994 |
61 | MP0000569_abnormal_digit_pigmentation | 1.23589031 |
62 | MP0001293_anophthalmia | 1.22853678 |
63 | MP0005408_hypopigmentation | 1.21034202 |
64 | MP0005257_abnormal_intraocular_pressure | 1.18450222 |
65 | MP0005248_abnormal_Harderian_gland | 1.18343072 |
66 | MP0004147_increased_porphyrin_level | 1.17119328 |
67 | MP0003191_abnormal_cellular_cholesterol | 1.17013970 |
68 | MP0000609_abnormal_liver_physiology | 1.16876228 |
69 | MP0006072_abnormal_retinal_apoptosis | 1.16667897 |
70 | MP0001764_abnormal_homeostasis | 1.16420368 |
71 | MP0005319_abnormal_enzyme/_coenzyme | 1.16158845 |
72 | MP0001666_abnormal_nutrient_absorption | 1.15547969 |
73 | MP0006054_spinal_hemorrhage | 1.13743732 |
74 | MP0002118_abnormal_lipid_homeostasis | 1.12479369 |
75 | MP0008007_abnormal_cellular_replicative | 1.12177190 |
76 | MP0002127_abnormal_cardiovascular_syste | 1.12069751 |
77 | MP0001984_abnormal_olfaction | 1.11721963 |
78 | MP0002332_abnormal_exercise_endurance | 1.11662839 |
79 | MP0000762_abnormal_tongue_morphology | 1.11470521 |
80 | MP0008789_abnormal_olfactory_epithelium | 1.10597518 |
81 | MP0003718_maternal_effect | 1.09168432 |
82 | MP0004883_abnormal_blood_vessel | 1.08241268 |
83 | MP0002138_abnormal_hepatobiliary_system | 1.04667065 |
84 | MP0000358_abnormal_cell_content/ | 1.02623502 |
85 | MP0009053_abnormal_anal_canal | 1.02296727 |
86 | MP0005197_abnormal_uvea_morphology | 1.02007681 |
87 | MP0005376_homeostasis/metabolism_phenot | 1.01943472 |
88 | MP0004381_abnormal_hair_follicle | 0.99346451 |
89 | MP0000647_abnormal_sebaceous_gland | 0.97996769 |
90 | MP0005551_abnormal_eye_electrophysiolog | 0.97768209 |
91 | MP0003656_abnormal_erythrocyte_physiolo | 0.96687088 |
92 | MP0005266_abnormal_metabolism | 0.95372985 |
93 | MP0004858_abnormal_nervous_system | 0.94025689 |
94 | MP0001879_abnormal_lymphatic_vessel | 0.92171562 |
95 | MP0002160_abnormal_reproductive_system | 0.92161778 |
96 | MP0003646_muscle_fatigue | 0.91498682 |
97 | MP0003566_abnormal_cell_adhesion | 0.90195119 |
98 | MP0001346_abnormal_lacrimal_gland | 0.85370468 |
99 | MP0005391_vision/eye_phenotype | 0.83349143 |
100 | MP0010771_integument_phenotype | 0.82391542 |
101 | MP0003868_abnormal_feces_composition | 0.81577317 |
102 | MP0005367_renal/urinary_system_phenotyp | 0.78348190 |
103 | MP0000516_abnormal_urinary_system | 0.78348190 |
104 | MP0002735_abnormal_chemical_nociception | 0.77861336 |
105 | MP0005023_abnormal_wound_healing | 0.77313448 |
106 | MP0002653_abnormal_ependyma_morphology | 0.77008168 |
107 | MP0005164_abnormal_response_to | 0.76877442 |
108 | MP0004782_abnormal_surfactant_physiolog | 0.76590881 |
109 | MP0003786_premature_aging | 0.76560718 |
110 | MP0005670_abnormal_white_adipose | 0.75163198 |
111 | MP0008004_abnormal_stomach_pH | 0.74962497 |
112 | MP0002098_abnormal_vibrissa_morphology | 0.74432242 |
113 | MP0005377_hearing/vestibular/ear_phenot | 0.73179327 |
114 | MP0003878_abnormal_ear_physiology | 0.73179327 |
115 | MP0002295_abnormal_pulmonary_circulatio | 0.73077442 |
116 | MP0003638_abnormal_response/metabolism_ | 0.72600536 |
117 | MP0000566_synostosis | 0.71970614 |
118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71714065 |
119 | MP0005195_abnormal_posterior_eye | 0.70945486 |
120 | MP0000049_abnormal_middle_ear | 0.69341919 |
121 | MP0005395_other_phenotype | 0.68832970 |
122 | MP0006276_abnormal_autonomic_nervous | 0.67936278 |
123 | MP0003279_aneurysm | 0.67558193 |
124 | MP0003890_abnormal_embryonic-extraembry | 0.67530151 |
125 | MP0008872_abnormal_physiological_respon | 0.67098345 |
126 | MP0005165_increased_susceptibility_to | 0.66752636 |
127 | MP0000537_abnormal_urethra_morphology | 0.66471188 |
128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66135423 |
129 | MP0000579_abnormal_nail_morphology | 0.66097496 |
130 | MP0003950_abnormal_plasma_membrane | 0.65940523 |
131 | MP0004233_abnormal_muscle_weight | 0.65883447 |
132 | MP0002282_abnormal_trachea_morphology | 0.65422482 |
133 | MP0008877_abnormal_DNA_methylation | 0.64595420 |
134 | MP0005646_abnormal_pituitary_gland | 0.63701853 |
135 | MP0002132_abnormal_respiratory_system | 0.63598248 |
136 | MP0003937_abnormal_limbs/digits/tail_de | 0.63386097 |
137 | MP0003453_abnormal_keratinocyte_physiol | 0.63184227 |
138 | MP0008438_abnormal_cutaneous_collagen | 0.62879706 |
139 | MP0009643_abnormal_urine_homeostasis | 0.62407551 |
140 | MP0001243_abnormal_dermal_layer | 0.62319631 |
141 | MP0001216_abnormal_epidermal_layer | 0.62249169 |
142 | MP0000467_abnormal_esophagus_morphology | 0.62163354 |
143 | MP0005595_abnormal_vascular_smooth | 0.62161523 |
144 | MP0006035_abnormal_mitochondrial_morpho | 0.62041049 |
145 | MP0002177_abnormal_outer_ear | 0.61080413 |
146 | MP0009384_cardiac_valve_regurgitation | 0.60338647 |
147 | MP0005394_taste/olfaction_phenotype | 0.60259965 |
148 | MP0005499_abnormal_olfactory_system | 0.60259965 |
149 | MP0000538_abnormal_urinary_bladder | 0.59785280 |
150 | MP0000598_abnormal_liver_morphology | 0.59165860 |
151 | MP0001529_abnormal_vocalization | 0.58031475 |
152 | MP0006292_abnormal_olfactory_placode | 0.57901295 |
153 | MP0009046_muscle_twitch | 0.57166015 |
154 | MP0002736_abnormal_nociception_after | 0.54992966 |
155 | MP0002210_abnormal_sex_determination | 0.54948196 |
156 | MP0001929_abnormal_gametogenesis | 0.53923266 |
157 | MP0001697_abnormal_embryo_size | 0.53114932 |
158 | MP0005379_endocrine/exocrine_gland_phen | 0.52847100 |
159 | MP0002233_abnormal_nose_morphology | 0.50661067 |
160 | MP0001727_abnormal_embryo_implantation | 0.50381072 |
161 | MP0005389_reproductive_system_phenotype | 0.48321017 |
162 | MP0001485_abnormal_pinna_reflex | 0.48221860 |
163 | MP0010234_abnormal_vibrissa_follicle | 0.47749289 |
164 | MP0004215_abnormal_myocardial_fiber | 0.47061713 |
165 | MP0000427_abnormal_hair_cycle | 0.46128861 |
166 | MP0005193_abnormal_anterior_eye | 0.45113635 |
167 | MP0002111_abnormal_tail_morphology | 0.44704823 |
168 | MP0003755_abnormal_palate_morphology | 0.44025919 |
169 | MP0002085_abnormal_embryonic_tissue | 0.43980348 |
170 | MP0002092_abnormal_eye_morphology | 0.43357698 |
171 | MP0000653_abnormal_sex_gland | 0.42377849 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.82010017 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.52592261 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.98243460 |
4 | Hypoplasia of the fovea (HP:0007750) | 4.95708889 |
5 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.95708889 |
6 | Hypobetalipoproteinemia (HP:0003563) | 4.94051848 |
7 | Patchy hypopigmentation of hair (HP:0011365) | 4.91486863 |
8 | White forelock (HP:0002211) | 4.61984439 |
9 | Xanthomatosis (HP:0000991) | 4.46503741 |
10 | Deep venous thrombosis (HP:0002625) | 4.42388968 |
11 | Abnormality of the fovea (HP:0000493) | 4.28078935 |
12 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.99430848 |
13 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83667523 |
14 | Hypolipoproteinemia (HP:0010981) | 3.74253835 |
15 | Prolonged partial thromboplastin time (HP:0003645) | 3.73443971 |
16 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.70075561 |
17 | Increased CSF lactate (HP:0002490) | 3.59962510 |
18 | Mitochondrial inheritance (HP:0001427) | 3.51542031 |
19 | Supernumerary spleens (HP:0009799) | 3.49804592 |
20 | Hyperglycinuria (HP:0003108) | 3.41504087 |
21 | Progressive macrocephaly (HP:0004481) | 3.37813651 |
22 | Epidermoid cyst (HP:0200040) | 3.33881142 |
23 | Hyperglycinemia (HP:0002154) | 3.25845372 |
24 | Abnormality of methionine metabolism (HP:0010901) | 3.23443112 |
25 | Hypoalphalipoproteinemia (HP:0003233) | 3.17888140 |
26 | Complement deficiency (HP:0004431) | 3.16707787 |
27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.15837041 |
28 | Abnormality of glycine metabolism (HP:0010895) | 3.09126039 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.09126039 |
30 | Abnormal hemoglobin (HP:0011902) | 3.08229356 |
31 | Cerebral edema (HP:0002181) | 3.07914810 |
32 | Fat malabsorption (HP:0002630) | 3.04740209 |
33 | Hepatocellular necrosis (HP:0001404) | 3.04320033 |
34 | Hyperammonemia (HP:0001987) | 3.03779145 |
35 | Hepatic necrosis (HP:0002605) | 3.01210383 |
36 | Increased hepatocellular lipid droplets (HP:0006565) | 2.99305150 |
37 | Hyperlipoproteinemia (HP:0010980) | 2.97521596 |
38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91814936 |
39 | Lipid accumulation in hepatocytes (HP:0006561) | 2.90813693 |
40 | Stenosis of the external auditory canal (HP:0000402) | 2.88079743 |
41 | Joint hemorrhage (HP:0005261) | 2.87765180 |
42 | Delayed CNS myelination (HP:0002188) | 2.82817343 |
43 | Ocular albinism (HP:0001107) | 2.82069508 |
44 | Albinism (HP:0001022) | 2.79374659 |
45 | Parakeratosis (HP:0001036) | 2.78922962 |
46 | Abnormality of alanine metabolism (HP:0010916) | 2.75540278 |
47 | Hyperalaninemia (HP:0003348) | 2.75540278 |
48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.75540278 |
49 | Increased serum lactate (HP:0002151) | 2.75229840 |
50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.73444113 |
51 | Hypoglycemic coma (HP:0001325) | 2.73416032 |
52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.72247539 |
53 | Iris hypopigmentation (HP:0007730) | 2.68690047 |
54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.68115460 |
55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.68115460 |
56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.68100801 |
57 | Abnormality of complement system (HP:0005339) | 2.67056947 |
58 | Lethargy (HP:0001254) | 2.64611825 |
59 | Generalized hypopigmentation (HP:0007513) | 2.61084547 |
60 | Vascular calcification (HP:0004934) | 2.59788186 |
61 | Steatorrhea (HP:0002570) | 2.56103821 |
62 | Lactic acidosis (HP:0003128) | 2.55739871 |
63 | Distal lower limb muscle weakness (HP:0009053) | 2.55119272 |
64 | Renal Fanconi syndrome (HP:0001994) | 2.45025718 |
65 | Blue irides (HP:0000635) | 2.44516489 |
66 | Type I transferrin isoform profile (HP:0003642) | 2.43155479 |
67 | Respiratory failure (HP:0002878) | 2.38704136 |
68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.38114377 |
69 | Cardiovascular calcification (HP:0011915) | 2.34518585 |
70 | Acute encephalopathy (HP:0006846) | 2.32710832 |
71 | Alopecia of scalp (HP:0002293) | 2.32352581 |
72 | Abnormality of secondary sexual hair (HP:0009888) | 2.32169452 |
73 | Abnormality of the axillary hair (HP:0100134) | 2.32169452 |
74 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.31336869 |
75 | Pancreatic cysts (HP:0001737) | 2.29092417 |
76 | Leukodystrophy (HP:0002415) | 2.27902100 |
77 | Birth length less than 3rd percentile (HP:0003561) | 2.26449239 |
78 | Poor head control (HP:0002421) | 2.24912444 |
79 | Nausea (HP:0002018) | 2.24293799 |
80 | Meckel diverticulum (HP:0002245) | 2.24201599 |
81 | Hypercholesterolemia (HP:0003124) | 2.23065262 |
82 | Abnormality of the anterior horn cell (HP:0006802) | 2.23001104 |
83 | Degeneration of anterior horn cells (HP:0002398) | 2.23001104 |
84 | Abnormality of midbrain morphology (HP:0002418) | 2.21056855 |
85 | Molar tooth sign on MRI (HP:0002419) | 2.21056855 |
86 | Pancreatic fibrosis (HP:0100732) | 2.20744277 |
87 | Abnormality of serum amino acid levels (HP:0003112) | 2.20696285 |
88 | Methylmalonic aciduria (HP:0012120) | 2.20314757 |
89 | Back pain (HP:0003418) | 2.17297143 |
90 | Hypothermia (HP:0002045) | 2.17263606 |
91 | Ketosis (HP:0001946) | 2.16739540 |
92 | Premature graying of hair (HP:0002216) | 2.16376335 |
93 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15946379 |
94 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.15494956 |
95 | Abnormal ciliary motility (HP:0012262) | 2.14416435 |
96 | Abnormality of the ileum (HP:0001549) | 2.14364105 |
97 | Acute necrotizing encephalopathy (HP:0006965) | 2.13766786 |
98 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13332371 |
99 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.13035113 |
100 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12423650 |
101 | Abnormal protein glycosylation (HP:0012346) | 2.12423650 |
102 | Abnormal glycosylation (HP:0012345) | 2.12423650 |
103 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12423650 |
104 | Abnormal number of erythroid precursors (HP:0012131) | 2.10706801 |
105 | True hermaphroditism (HP:0010459) | 2.10575806 |
106 | Chromsome breakage (HP:0040012) | 2.08127481 |
107 | Esophageal varix (HP:0002040) | 2.07462000 |
108 | Right ventricular cardiomyopathy (HP:0011663) | 2.05904794 |
109 | Adrenal hypoplasia (HP:0000835) | 2.05858067 |
110 | Neonatal onset (HP:0003623) | 2.04953304 |
111 | Absent radius (HP:0003974) | 2.04735994 |
112 | Exercise intolerance (HP:0003546) | 2.02537485 |
113 | Hypokinesia (HP:0002375) | 2.02232757 |
114 | Hypochromic microcytic anemia (HP:0004840) | 2.02049349 |
115 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.01806988 |
116 | Large for gestational age (HP:0001520) | 2.01729530 |
117 | Cerebral hypomyelination (HP:0006808) | 2.01603093 |
118 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.01497139 |
119 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.01497139 |
120 | Facial cleft (HP:0002006) | 2.01350301 |
121 | Abnormal auditory evoked potentials (HP:0006958) | 1.99461174 |
122 | Dicarboxylic aciduria (HP:0003215) | 1.99005875 |
123 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99005875 |
124 | Hepatocellular carcinoma (HP:0001402) | 1.98414185 |
125 | Spastic paraparesis (HP:0002313) | 1.98332397 |
126 | Rickets (HP:0002748) | 1.97966813 |
127 | Sparse eyelashes (HP:0000653) | 1.97601925 |
128 | Hyperbilirubinemia (HP:0002904) | 1.97146512 |
129 | Cholelithiasis (HP:0001081) | 1.96011737 |
130 | Methylmalonic acidemia (HP:0002912) | 1.95425306 |
131 | Myocardial infarction (HP:0001658) | 1.95232089 |
132 | CNS demyelination (HP:0007305) | 1.95074434 |
133 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93813895 |
134 | Cutaneous melanoma (HP:0012056) | 1.93612655 |
135 | Asplenia (HP:0001746) | 1.93605960 |
136 | Reticulocytopenia (HP:0001896) | 1.92457275 |
137 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91844746 |
138 | Abnormal gallbladder morphology (HP:0012437) | 1.90898549 |
139 | Abnormality of chromosome stability (HP:0003220) | 1.90229388 |
140 | Optic disc pallor (HP:0000543) | 1.89270130 |
141 | Absent forearm bone (HP:0003953) | 1.89004064 |
142 | Aplasia involving forearm bones (HP:0009822) | 1.89004064 |
143 | Abnormal lung lobation (HP:0002101) | 1.88865495 |
144 | Skin nodule (HP:0200036) | 1.88662956 |
145 | Metabolic acidosis (HP:0001942) | 1.88412836 |
146 | Malnutrition (HP:0004395) | 1.87144473 |
147 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.86556004 |
148 | Spontaneous abortion (HP:0005268) | 1.85187980 |
149 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84121055 |
150 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.83021758 |
151 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.82638954 |
152 | Megaloblastic anemia (HP:0001889) | 1.81479835 |
153 | Chronic bronchitis (HP:0004469) | 1.81391270 |
154 | Abdominal situs inversus (HP:0003363) | 1.81336181 |
155 | Abnormality of abdominal situs (HP:0011620) | 1.81336181 |
156 | Abnormality of glycolysis (HP:0004366) | 1.80213300 |
157 | Increased serum pyruvate (HP:0003542) | 1.80213300 |
158 | Vomiting (HP:0002013) | 1.79360157 |
159 | Rhinitis (HP:0012384) | 1.79323692 |
160 | Testicular atrophy (HP:0000029) | 1.79190958 |
161 | Respiratory distress (HP:0002098) | 1.78468028 |
162 | Confusion (HP:0001289) | 1.76678245 |
163 | Nephronophthisis (HP:0000090) | 1.76379792 |
164 | Reduced antithrombin III activity (HP:0001976) | 1.75889833 |
165 | Abnormality of iron homeostasis (HP:0011031) | 1.74508354 |
166 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.74166214 |
167 | Hypopigmentation of the fundus (HP:0007894) | 1.72364536 |
168 | Bile duct proliferation (HP:0001408) | 1.71706430 |
169 | Abnormal biliary tract physiology (HP:0012439) | 1.71706430 |
170 | Abnormality of the preputium (HP:0100587) | 1.71013597 |
171 | Recurrent corneal erosions (HP:0000495) | 1.70008287 |
172 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.69958198 |
173 | Small intestinal stenosis (HP:0012848) | 1.69777170 |
174 | Duodenal stenosis (HP:0100867) | 1.69777170 |
175 | Irritability (HP:0000737) | 1.69674451 |
176 | Spastic diplegia (HP:0001264) | 1.68311089 |
177 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.68298586 |
178 | Natal tooth (HP:0000695) | 1.68050602 |
179 | Cortical dysplasia (HP:0002539) | 1.64451086 |
180 | Ulnar claw (HP:0001178) | 1.64016374 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 4.64712866 |
2 | GRK1 | 3.70442484 |
3 | MST4 | 2.91370925 |
4 | LATS2 | 2.84744415 |
5 | VRK2 | 2.68623301 |
6 | EPHA2 | 2.68499964 |
7 | EIF2AK1 | 2.67376221 |
8 | GRK5 | 2.59282249 |
9 | EPHB2 | 2.58727541 |
10 | MAPKAPK3 | 2.57435008 |
11 | BCKDK | 2.55634702 |
12 | PBK | 2.54112399 |
13 | GRK7 | 2.49800885 |
14 | NME2 | 2.48750728 |
15 | STK16 | 2.41027817 |
16 | AKT3 | 2.36191531 |
17 | CASK | 2.26721132 |
18 | CDC7 | 2.02519111 |
19 | EIF2AK3 | 2.02496010 |
20 | RPS6KB2 | 1.90023390 |
21 | FER | 1.84818811 |
22 | MST1R | 1.79777073 |
23 | TRIM28 | 1.77103765 |
24 | ERBB4 | 1.64843557 |
25 | MAP4K2 | 1.64306787 |
26 | NUAK1 | 1.64305321 |
27 | NME1 | 1.56105288 |
28 | PLK2 | 1.45331194 |
29 | MOS | 1.42830135 |
30 | AURKA | 1.39394361 |
31 | DAPK2 | 1.34212024 |
32 | CSNK1G3 | 1.32427152 |
33 | ADRBK2 | 1.32337923 |
34 | BRSK2 | 1.29353539 |
35 | BCR | 1.28705430 |
36 | STK38L | 1.28593121 |
37 | TLK1 | 1.28438013 |
38 | MAP2K1 | 1.28296995 |
39 | FRK | 1.26998260 |
40 | NTRK1 | 1.25780934 |
41 | MAP2K2 | 1.25010215 |
42 | MAP3K3 | 1.22091240 |
43 | MYLK | 1.21448872 |
44 | CSNK1G2 | 1.21053127 |
45 | MAPK15 | 1.20559268 |
46 | MATK | 1.20492108 |
47 | CSNK1G1 | 1.18727077 |
48 | MET | 1.15559555 |
49 | TRPM7 | 1.15031629 |
50 | NEK9 | 1.12644510 |
51 | BUB1 | 1.08640837 |
52 | TGFBR2 | 1.05803729 |
53 | EPHA3 | 1.03300657 |
54 | FGFR4 | 1.01137176 |
55 | WNK3 | 1.00899626 |
56 | BRSK1 | 0.99460223 |
57 | CHEK2 | 0.99231920 |
58 | ADRBK1 | 0.98295286 |
59 | CSNK1A1L | 0.97558993 |
60 | MAP3K12 | 0.97392632 |
61 | WEE1 | 0.91287605 |
62 | INSRR | 0.90136147 |
63 | NEK1 | 0.89160825 |
64 | CCNB1 | 0.88563255 |
65 | ATR | 0.88281867 |
66 | TGFBR1 | 0.85664461 |
67 | PAK4 | 0.82062474 |
68 | MAP2K4 | 0.81900317 |
69 | PIK3CG | 0.81375098 |
70 | PASK | 0.80831208 |
71 | MAP3K11 | 0.80458072 |
72 | CDK6 | 0.78934918 |
73 | PTK6 | 0.78712757 |
74 | PTK2 | 0.77989946 |
75 | MKNK2 | 0.74803472 |
76 | ABL2 | 0.74678062 |
77 | STK39 | 0.73492586 |
78 | ZAK | 0.72292234 |
79 | TAF1 | 0.70891599 |
80 | ERBB2 | 0.70460520 |
81 | TTK | 0.70007216 |
82 | CDK7 | 0.69796920 |
83 | ERN1 | 0.68672896 |
84 | STK10 | 0.68007876 |
85 | PDK2 | 0.67282838 |
86 | MARK3 | 0.67222296 |
87 | BMPR1B | 0.66631237 |
88 | KDR | 0.66118740 |
89 | PTK2B | 0.65637954 |
90 | SRPK1 | 0.65528633 |
91 | NEK2 | 0.65015101 |
92 | MKNK1 | 0.63102946 |
93 | PLK4 | 0.62635228 |
94 | GSK3A | 0.62540291 |
95 | WNK4 | 0.61360206 |
96 | PNCK | 0.60575601 |
97 | DYRK2 | 0.59813109 |
98 | CAMK2G | 0.59460181 |
99 | ERBB3 | 0.59051679 |
100 | LRRK2 | 0.58333400 |
101 | MAPKAPK5 | 0.57791677 |
102 | CSNK2A2 | 0.56921184 |
103 | BMPR2 | 0.56669699 |
104 | MAPKAPK2 | 0.56451669 |
105 | MAP3K2 | 0.55610891 |
106 | TSSK6 | 0.54830644 |
107 | CDK8 | 0.54247423 |
108 | PRKCG | 0.53883716 |
109 | PRKCI | 0.53445340 |
110 | CSNK2A1 | 0.52568319 |
111 | CSNK1E | 0.50704111 |
112 | FLT3 | 0.50183685 |
113 | TIE1 | 0.50018514 |
114 | DDR2 | 0.49191808 |
115 | STK3 | 0.47523978 |
116 | PIM2 | 0.47098752 |
117 | DAPK3 | 0.46527038 |
118 | PLK1 | 0.46475022 |
119 | PRKD3 | 0.45616546 |
120 | VRK1 | 0.45419112 |
121 | PRKCE | 0.45127578 |
122 | PRKD1 | 0.44932982 |
123 | CDK3 | 0.44906355 |
124 | ATM | 0.44345524 |
125 | PINK1 | 0.43211248 |
126 | AURKB | 0.43041935 |
127 | EIF2AK2 | 0.42119917 |
128 | PLK3 | 0.40507775 |
129 | PRKACG | 0.40454141 |
130 | SIK1 | 0.39993112 |
131 | PAK1 | 0.39802814 |
132 | RPS6KA5 | 0.39675948 |
133 | LIMK1 | 0.38982160 |
134 | CSNK1A1 | 0.38258268 |
135 | CDK12 | 0.38188832 |
136 | LATS1 | 0.36848205 |
137 | MAPK4 | 0.36760717 |
138 | PDK4 | 0.36074300 |
139 | PDK3 | 0.36074300 |
140 | OXSR1 | 0.34949873 |
141 | CAMK2D | 0.31949689 |
142 | AKT2 | 0.29515897 |
143 | RPS6KA4 | 0.28777055 |
144 | MUSK | 0.27686815 |
145 | CHEK1 | 0.27567579 |
146 | FGFR1 | 0.26473130 |
147 | IRAK3 | 0.26384546 |
148 | DAPK1 | 0.22951878 |
149 | MAP3K8 | 0.22938296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.78273872 |
2 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.25125868 |
3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.02945265 |
4 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.87806565 |
5 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.64006115 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.62205617 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54197323 |
8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51522676 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49470490 |
10 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.41501200 |
11 | Protein export_Homo sapiens_hsa03060 | 2.40666999 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38344450 |
13 | Homologous recombination_Homo sapiens_hsa03440 | 2.34622431 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32207703 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.23823361 |
16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20029421 |
17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97079905 |
18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95921623 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92914331 |
20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88357471 |
21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.87516576 |
22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.82885775 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.78224105 |
24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.74809329 |
25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.73635605 |
26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73618691 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72034469 |
28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.70530530 |
29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70311060 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66828030 |
31 | Ribosome_Homo sapiens_hsa03010 | 1.66081838 |
32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62524801 |
33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51280186 |
34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51235816 |
35 | Proteasome_Homo sapiens_hsa03050 | 1.50816489 |
36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50706861 |
37 | Base excision repair_Homo sapiens_hsa03410 | 1.50669956 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49951589 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.48235310 |
40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47631697 |
41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42933327 |
42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35029331 |
43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33827094 |
44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31544050 |
45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30078775 |
46 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28841324 |
47 | Bile secretion_Homo sapiens_hsa04976 | 1.24870229 |
48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22131614 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21846041 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20308056 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20074850 |
52 | RNA transport_Homo sapiens_hsa03013 | 1.19033413 |
53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17204352 |
54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15933635 |
55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13531854 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13483728 |
57 | RNA degradation_Homo sapiens_hsa03018 | 1.10472945 |
58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10381144 |
59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08246044 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08112261 |
61 | Spliceosome_Homo sapiens_hsa03040 | 1.07714103 |
62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03190964 |
63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98167264 |
64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97671376 |
65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97626099 |
66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93289785 |
67 | Cell cycle_Homo sapiens_hsa04110 | 0.91047308 |
68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88950443 |
69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86608149 |
70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85454293 |
71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81905858 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81546989 |
73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79742776 |
74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78982328 |
75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78285023 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72126280 |
77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72095912 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68317790 |
79 | ABC transporters_Homo sapiens_hsa02010 | 0.67454000 |
80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64205284 |
81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64168020 |
82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63673549 |
83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63604177 |
84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60586947 |
85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59209158 |
86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55643418 |
87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54160785 |
88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53699693 |
89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53663167 |
90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53015507 |
91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50760019 |
92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50742397 |
93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45300420 |
94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41993541 |
95 | Phototransduction_Homo sapiens_hsa04744 | 0.41504358 |
96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38681083 |
97 | Mismatch repair_Homo sapiens_hsa03430 | 0.36869297 |
98 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35162955 |
99 | RNA polymerase_Homo sapiens_hsa03020 | 0.34908141 |
100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34756071 |
101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34321537 |
102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33519669 |
103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32790198 |
104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32612542 |
105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29593534 |
106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.28073675 |
107 | Prion diseases_Homo sapiens_hsa05020 | 0.27423256 |
108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27235700 |
109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25496499 |
110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23629562 |
111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.20641098 |
112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.17454047 |
113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.16551119 |
114 | Bladder cancer_Homo sapiens_hsa05219 | 0.12226642 |
115 | Mineral absorption_Homo sapiens_hsa04978 | 0.10861948 |
116 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.09097416 |
117 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.09031641 |
118 | DNA replication_Homo sapiens_hsa03030 | 0.08637233 |
119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.08494297 |
120 | Purine metabolism_Homo sapiens_hsa00230 | 0.08433614 |
121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.08217551 |
122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05072421 |
123 | Melanoma_Homo sapiens_hsa05218 | 0.04964582 |